Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Links

Showing results (191-200 of 345) with videos related to

Pageof 35
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 21, 2007
A phase II trial of imatinib therapy for metastatic medullary thyroid carcinomaJ W B de Groot, B A Zonnenberg, P Quarles van Ufford-Mannesse, et al.
Thyroid : Official Journal of the American Thyroid Association|November 25, 2006
Biochemical markers in the follow-up of medullary thyroid cancerJan Willem B de Groot, Ido P Kema, Henk Breukelman, et al.
World Journal of Surgery|October 27, 2022
Thyroid Lobectomy for Low-Risk 1-4 CM Papillary Thyroid Cancer is not Associated with Increased Recurrence Rates in the Dutch Population with a Restricted Diagnostic Work-UpJ F Lin, P M Rodriguez Schaap, M J H Metman, et al.
Cancer|November 6, 2009
Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancerMartin A Walter, Christian Meier, Tanja Radimerski, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
Radiation optic neuropathy after external beam radiation therapy for acromegalyAlfons C M van den Bergh, Robin P F Dullaart, Marjanke A Hoving, et al.
European Journal of Endocrinology|January 10, 2015
Therapy of endocrine disease: response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysisE N Klein Hesselink, D Steenvoorden, E Kapiteijn, et al.
Familial Cancer|May 16, 2019
The incidence of consecutive manifestations in Von Hippel-Lindau diseaseAnouk N A van der Horst-Schrivers, Wim J Sluiter, Roeliene C Kruizinga, et al.
Endocrine-Related Cancer|May 7, 2017
Risk factors for venous thromboembolism in patients treated for differentiated thyroid carcinomaTrynke van der Boom, Esther N Klein Hesselink, Hilde A M Kooistra, et al.
European Journal of Endocrinology|May 30, 2003
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulinK M van Tol, P L Jager, E G E de Vries, et al.
Clinical Chemistry and Laboratory Medicine|February 4, 2018
Platelet serotonin is not elevated in patients with benign head and neck paragangliomasAnnika M A Berends, Karin Eijkelenkamp, Thamara E Osinga, et al.
Pageof 35

Showing results (191-200 of 345) with videos related to

Sort By:
Pageof 35
The Journal of Clinical Endocrinology and Metabolism|June 21, 2007
A phase II trial of imatinib therapy for metastatic medullary thyroid carcinomaJ W B de Groot, B A Zonnenberg, P Quarles van Ufford-Mannesse, et al.
Thyroid : Official Journal of the American Thyroid Association|November 25, 2006
Biochemical markers in the follow-up of medullary thyroid cancerJan Willem B de Groot, Ido P Kema, Henk Breukelman, et al.
World Journal of Surgery|October 27, 2022
Thyroid Lobectomy for Low-Risk 1-4 CM Papillary Thyroid Cancer is not Associated with Increased Recurrence Rates in the Dutch Population with a Restricted Diagnostic Work-UpJ F Lin, P M Rodriguez Schaap, M J H Metman, et al.
Cancer|November 6, 2009
Procalcitonin levels predict clinical course and progression-free survival in patients with medullary thyroid cancerMartin A Walter, Christian Meier, Tanja Radimerski, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 16, 2003
Radiation optic neuropathy after external beam radiation therapy for acromegalyAlfons C M van den Bergh, Robin P F Dullaart, Marjanke A Hoving, et al.
European Journal of Endocrinology|January 10, 2015
Therapy of endocrine disease: response and toxicity of small-molecule tyrosine kinase inhibitors in patients with thyroid carcinoma: a systematic review and meta-analysisE N Klein Hesselink, D Steenvoorden, E Kapiteijn, et al.
Familial Cancer|May 16, 2019
The incidence of consecutive manifestations in Von Hippel-Lindau diseaseAnouk N A van der Horst-Schrivers, Wim J Sluiter, Roeliene C Kruizinga, et al.
Endocrine-Related Cancer|May 7, 2017
Risk factors for venous thromboembolism in patients treated for differentiated thyroid carcinomaTrynke van der Boom, Esther N Klein Hesselink, Hilde A M Kooistra, et al.
European Journal of Endocrinology|May 30, 2003
Outcome in patients with differentiated thyroid cancer with negative diagnostic whole-body scanning and detectable stimulated thyroglobulinK M van Tol, P L Jager, E G E de Vries, et al.
Clinical Chemistry and Laboratory Medicine|February 4, 2018
Platelet serotonin is not elevated in patients with benign head and neck paragangliomasAnnika M A Berends, Karin Eijkelenkamp, Thamara E Osinga, et al.
Pageof 35